NVIDIA CORP (NVDA) investment division holdings of US-listed stocks. NVDIA's holdings include publicly traded stocks in the semiconductor, AI, and pharmaceutical industries. NVIDIA's status in AI and the semiconductor industries add significant market credibility to its investees, and also hints at deeper future collaborations and a positive outlook for these companies' growth.
$Arm Holdings (ARM.US)$ $Microsoft (MSFT.US)$
$Serve Robotics (SERV.US)$
$Blackrock (BLK.US)$
$NVIDIA (NVDA.US)$
Ghisallo Capital Management LLC Makes New Investment in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma
• First program to combine Recursion's end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months
• Plan to initiate dosing of Phase 1/2 in Q4 2024 to evaluate REC-1245 in a biomarker enriched patient po...
Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-in-Class Rbm39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma
I wouldn't go hog wild on this company right now you can go back and see it was rallying and then the stock falls but you have to look beyond the short-term price movement and look at where the company ultimately could be in 5 years.
so if you trade this company and you're able to pull out a profit ...
No comment yet